Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | METROPOLIS Metropolis Healthcare Limited Pharma · Micro | THYROCARE Thyrocare Technologies Limited Pharma · Micro | NIDAN Nidan Laboratories And Healthcare Ltd. Pharma · SME | INVICTA Invicta Diagnostic Ltd. Pharma · SME |
|---|---|---|---|---|
| Final Score | 38 | 52 | 36 | 61 |
| Verdict | WATCHLIST | FAIR VALUE | WATCHLIST | UNDERVALUED |
| Style | WATCHLIST | Premium Compounder | WATCHLIST | Growth at Value |
| Piotroski | 8/9 | 8/9 | 6/9 | 8/9 |
| Valuation | 0/30 | 0/30 | 20/30 | 19/30 |
| Growth | 8/25 | 12/25 | 4/25 | 22/25 |
| Quality | 9/20 | 20/20 | 0/20 | 8/20 |
| Balance Sheet | 9/15 | 8/15 | 8/15 | 13/15 |
| Cash Flow | 7/10 | 8/10 | 8/10 | 1/10 |
| Price | ₹534 | ₹549 | ₹14 | ₹61.2 |
| P/E | 56.00 | 53.80 | 11.10 | 16.40 |
| P/B | 7.26 | 14.70 | 0.28 | 1.62 |
| ROE | 13.80% | 28.40% | 2.55% | 14.70% |
| ROCE | 17.80% | 35.40% | 5.99% | 20.30% |
| Debt / Equity | 0.15 | 0.09 | 0.16 | 0.07 |
| FCF Yield | 1.16% | 2.20% | 8.87% | — |
| Dividend Y | 0.38% | 1.72% | — | — |
| Altman Z | 8.61 | 9.35 | 2.54 | 6.93 |
| Promoter % | 48.86% | 60.92% | 57.04% | 66.70% |
| Mkt Cap (₹Cr) | 10990.00 | 8649.00 | 19.50 | 80.80 |
| Graham # | ₹122.73 | ₹92.08 | ₹35.05 | ₹59.1 |
| Fair PE | 8.7 | 23.5 | 5.4 | 42.0 |
| MoS % | -568.5% | -128.3% | -137.8% | +62.7% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startMETROPOLIS25
THYROCARE56
NIDAN30
INVICTA71